DARRYL HOOKER: Open Payments
NPI 1821402165 · OXON HILL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 22 payments from 7 companies in 2025. Trend: 2023 $818 · 2024 $532 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $301 |
| Novo Nordisk Inc | 3 | $164 |
| Lilly USA, LLC | 4 | $153 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Amgen Inc. | 2 | $39 |
| Alkermes, Inc. | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $23 |
Products named: VRAYLAR, Wegovy, ZEPBOUND, UBRELVY, JARDIANCE, MOUNJARO, REPATHA, QULIPTA.
Industry payments across MD — which companies pay providers there.
